Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
Turnstone reports second quarter 2024 financial results and provides recent business highlights
Turnstone Biologics
Business Services · California, United States · 82 Employees
View Company Info for Free
About
Headquarters
9310 Athena Cir Ste 300, La Jolla, California, ...Phone Number
(347) 897-5988Website
www.turnstonebio.comRevenue
$19.3 MillionStock Symbol
TSBXIndustry
Most Recent Scoops
May 20 2024
Earnings
May 20 2024
Earnings
Highlights
$132.7M
Total Funding Amount
$80M
Most Recent Funding Amount
3
Number of Funding Rounds
Who is Turnstone Biologics
Turnstone is developing a disruptive class of engineered viral immunotherapies, attacking cancer's complexity with medicines designed to fight mali gnant disease at multiple points of intervention. Turnstone's proprietary vaccinia virus platform has been engineered to stimulate the immune system, drive antigen presentation and recognition, and re-shape the tumor microenvironment. In addition, the large transgene capacity of the virus can be utilized to deliver other agents and therapeutics directly to sites of tumors throughout the body for local expression, reducing the potential for systemic toxicity.Read more
Turnstone Biologics Org Chart
Is Turnstone Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Turnstone Biologics had a recent Job posting/layoffs
Check if Turnstone Biologics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Turnstone Biologics has new funding data
Check out if Turnstone Biologics is spiking on competitors!
Turnstone Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Turnstone Biologics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Turnstone Biologics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Turnstone Biologics launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Similar Companies to Turnstone Biologics
Analyze insights from companies similar to Turnstone Biologics and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
- Oncorus82
$18.8M - Checkmate Pharmaceuticals30$10.1M
- NextCure82$27.7M
- Harpoon Therapeutics53$37.3M
- iTeos Therapeutics157$35M
- Eureka Therapeutics67$40M
- Surface Oncology67$31.1M
- Morphogenesis27$18.5M
More similar companies
Turnstone Biologics financials insights
Gather financial insights about Turnstone Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Turnstone Biologics Employee Growth Rate
View Turnstone Biologics’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
Turnstone Biologics Tech Stack
A closer look at the technologies used by Turnstone Biologics
See more technologies
Most Recent Scoops
May 20 2024
Earnings
May 20 2024
Earnings
Product Development, Product Management
May 20 2024
Earnings
May 20 2024
Earnings
May 20 2024
Earnings
Turnstone Biologics News & Media
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
ORR of 25% and 50% DCR observed in first four evaluable patients treated with TIDAL-01 with advanced CRCTurnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
Turnstone Biologics Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsTurnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
Dr. Sammy Farah, Turnstone's President and CEO, to present at the 2024 Bank of America Securities Health Care Conference in Las Vegas, NV.Turnstone Biologics Appoints William Waddill to its Board of Directors
Turnstone Biologics appoints biotechnology industry veteran, William Waddill, to its Board of Directors.
Read more news
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Turnstone Biologics
Turnstone is developing a disruptive class of engineered viral immunotherapies, attacking cancer's complexity with medicines designed to fight malignant disease at multiple points of intervention. Turnstone's proprietary vaccinia virus platform has been engineered to stimulate the immune system, drive antigen presentation and recognition, and re-sh... Read More
